Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Izumi Finance (IZI) Price & Performance

InjectiveTrade
Izumi FinanceTrade

Price performance (Past 24H)

Key statistics

Injective vs Izumi Finance — how do they compare? Injective trades at Rp92,735 (market cap Rp9,29T, Rp1,82T 24h volume), while Izumi Finance trades at Rp26.85 (market cap Rp32,06M, Rp254,85jt 24h volume). The key difference: Injective is far larger — about 289769.2× Izumi Finance's market cap, and Izumi Finance's supply is capped (787,4M / 2B IZI (40%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Izumi Finance for 10 Days on average.

INJIZI
Market Cap
Rp9,29TRp32,06M
Volume (24h)
Rp1,82TRp254,85jt
Circulating Supply
100M INJ787,4M / 2B IZI (40%)
Typical Hold Time
36 Days10 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Izumi Finance

Izumi Finance (IZI) holds a market cap of Rp32.06M with a circulating supply of 787.4 million tokens out of a 2 million max supply, indicating a 40% circulation rate. Current price data is unavailable, but the token shows a hold time of 10 days, suggesting moderate trader retention. No recent protocol updates or ecosystem news are noted, with technical analysis limited due to missing price metrics.

Overall outlook is cautious due to low market cap and limited liquidity. Key opportunities include potential ecosystem growth if adoption increases, but major risks involve high volatility from low trading volume and regulatory uncertainties in the crypto space. Investors should monitor on-chain activity for signs of network engagement.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
IZI

No sentiment data available yet.

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Izumi Finance

Izumi Finance provides Programmable Liquidity as a Service (LaaS) on Ethereum with Uniswap V3 and plans to expand to multiple chains with integrated DEXs. This service allows liquidity providers to earn extra liquidity mining rewards and trading fees. It also helps protocols attract and maintain liquidity effectively. Izumi improves incentive distribution through its LiquidBox, allowing rewards to be allocated within specific price ranges.

Read more on IZI